Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Orphan Disease Designation like IPF?

About IPF

Idiopathic pulmonary fibrosis, an orphan disease, is a type of chronic lung condition characterized by a progressive and irreversible decline in lung function and scarring (fibrosis) of the lungs. There is no cure for IPF and there are currently no procedures or medications that can remove the scarring from the lungs.


https://www.globenewswire.com/news-release/2019/07/03/1877782/0/en/Algernon-Pharmaceuticals-NP-120-Reduced-Fibrosis-in-an-Idiopathic-Pulmonary-Fibrosis-Study-by-56-Outperforming-USFDA-Approved-Treatments-Nintedanib-and-Pirfenidone.html

Where/ Why/ When AGN/ Ifenprodil started...GLTA...